Research strategies and priorities to improve the lives of people with schizophrenia: Executive summary of the Ernst Struüngmann forum on schizophrenia

Schizophrenia Bulletin

Volumn 40, Issue 2, 2014, Pages 259-265

  Silverstein, Steven M ^a   Moghaddam, Bita ^b   Wykes, Til ^c  

^a University of Medicine and Dentistry of New Jersey   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN FUNCTION; CLINICAL FEATURE; CLINICAL TRIAL (TOPIC); COGNITIVE THERAPY; CONFERENCE PAPER; CONSENSUS; DISABILITY; EARLY INTERVENTION; FEEDBACK SYSTEM; FUNCTIONAL MAGNETIC RESONANCE IMAGING; FUNCTIONAL NEUROIMAGING; HEALTH CARE UTILIZATION; HEREDITY; HUMAN; INCIDENCE; INTEGRATION; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH RESEARCH; MENTAL HEALTH SERVICE; MENTAL PATIENT; MOTIVATION; NEUROBIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; RISK FACTOR; SCHIZOPHRENIA; SUBSTANCE ABUSE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT RESPONSE; VIRTUAL REALITY; ORGANIZATION;

CONGRESSES AS TOPIC; HUMANS; SCHIZOPHRENIA;

EID: 84895767903     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbt238     Document Type: Conference Paper

References (58)

1. Insel TR. Rethinking schizophrenia. Nature. 2010;468:187-193.
2. Wooding S, Pollitt A, Castle-Clarke S, et al. Mental Health Retrosight: Understanding the returns from research (lessons from schizophrenia): Policy Report. Santa Monica, CA: RAND Corp.; 2013.
3. SilversteinS, Moghaddam BT. Wykes T, eds. Schizophrenia: Evolution and Synthesis. Strüngmann Forum Reports, Vol 13. Cambridge, MA: MIT Press; 2013.
4. Heinrichs RW. In Search of Madness. New York: Oxford University Press; 2001.
5. Mitchell KJ, Porteous DJ. Rethinking the genetic architecture of schizophrenia. Psychol Med. 2011;41(1):19-32.
6. Sebat J, Levy DL, McCarthy SE. Rare structural variants in schizophrenia: one disorder, multiple mutations; one mutation, multiple disorders. Trends Genet. 2009;25:528-535.
7. Speed T. Mathematics. A correlation for the 21st century. Science. 2011;334:1502-1503.
8. Bora E, Murray RM. Meta-Analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis? Schizophr Bull. 2013.
9. Harvey PD. When does cognitive decline occur in the period prior to the first episode of schizophrenia? Psychiatry (Edgmont). 2009;6(7):12-14.
10. Bonner-Jackson A, Grossman LS, Harrow M, Rosen C. Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Compr Psychiatry. 2010;51:471-479.
11. Silverstein SM, Keane BP, Wang Y, et al., Effects of short-term inpatient treatment on sensitivity to a size contrast illusion in first-episode psychosis and multiple-episode schizophrenia. Front Psychol. 2013;4:466.
12. Neumann CS, Grimes K, Walker EF, Baum K. Developmental pathways to schizophrenia: behavioral subtypes. J Abnorm Psychol. 1995;104:558-566.
13. Jeste DV, Wolkowitz OM, Palmer BW. Divergent trajectories of physical, cognitive, and psychosocial aging in schizophrenia. Schizophr Bull. 2011;37:451-455.
14. Yung AR, Nelson B. Young people at ultra high risk for psychosis: a research update. Early Interv Psychiatry. 2011;5(suppl 1):52-57.
15. Morrison AP, French P, Stewart SLK, et al. Early detection and intervention evaluation for people at risk of psychosis: multisite randomised controlled trial. BMJ. 2012;344:e2233.
16. Renes RA, Vermeulenb L, Kahnb RS, Aartsa H, van Haren NEM. Abnormalities in the establishment of feeling of selfagency in schizophrenia. Schizophr Res. 2013;143(1):50-54.
17. Moghaddam B, Wood J. Teamwork Matters: Coordinated neuronal activity in brain systems relevant to psychiatric disorders. JAMA Psychiatr. In press.
18. Schobel SA, Chaudhury NH, Khan UA, et al. Imaging patients with psychosis and a mouse model establishes a spreading pattern of hippocampal dysfunction and implicates glutamate as a driver. Neuron. 2013;78(1):81-93.
19. Moghaddam B. A mechanistic approach to preventing schizophrenia in at-risk individuals. Neuron. 2013;78(1):1-3.
20. Lincoln TM, Peter N, Schäfer M, Moritz S. Impact of stress on paranoia: an experimental investigation of moderators and mediators. Psychol Med. 2009;39:1129-1139.
21. Ellett L, Freeman D, Garety PA. The psychological effect of an urban environment on individuals with persecutory delusions: the Camberwell walk study. Schizophr Res. 2008;99:77-84.
22. Oshima I, Mino Y, Inomata Y. Institutionalisation and schizophrenia in Japan: social environments and negative symptoms: Nationwide survey of in-patients. Br J Psychiatr. 2003;183:50-56.
23. Lehtinen V, Aaltonen J, Koffert T, Räkköläinen V, Syvälahti E. Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed? Eur Psychiatr. 2000;15:312-320.
24. Wykes T, Newton E, Landau S, Rice C, Thompson N, Frangou S. Cognitive remediation therapy (CRT) for young early onset patients with schizophrenia: an exploratory randomized controlled trial. Schizophr Res. 2007;94:221-230.
25. Ventura J, Wilson SA, Wood RC, Hellemann GS. Cognitive training at home in schizophrenia is feasible. Schizophr Res. 2013;143:397-398.
26. Wykes T, Huddy V, Cellard C, McGurk SR, Czobor P. A metaanalysis of cognitive remediation for schizophrenia: methodology and effect sizes. Am J Psychiatr. 2011;168:472-485.
27. Horrobin DF, Glen AI, Hudson CJ. Possible relevance of phospholipid abnormalities and genetic interactions in psychiatric disorders: the relationship between dyslexia and schizophrenia. Med Hypotheses. 1995;45:605-613.
28. Richardson AJ. Dyslexia, handedness and syndromes of psychosis- proneness. Int J Psychophysiol. 1994;18:251-263.
29. Leonard CM, Kuldau JM, Maron L, et al. Identical neural risk factors predict cognitive deficit in dyslexia and schizophrenia. Neuropsychology. 2008;22:147-158.
30. Simmers AJ, Bex PJ. Deficit of visual contour integration in dyslexia. Invest Ophthalmol Vis Sci. 2001;42:2737-2742.
31. Silverstein SM, Berten S, Essex B, Kovács I, Susmaras T, Little DM. An fMRI examination of visual integration in schizophrenia. J Integr Neurosci. 2009;8:175-202.
32. Silverstein SM, Palumbo DR. Nonverbal perceptual organization output disability and schizophrenia spectrum symptomatology. Psychiatry. 1995;58(1):66-81; discussion 2-4.
33. Lugnegard T, Unenge Hallerbäck M, Hjärthag F, Gillberg C. Social cognition impairments in Asperger syndrome and schizophrenia. Schizophr Res. 2013;143:277-284.
34. Stone WS, Iguchi L. Do apparent overlaps between schizophrenia and autistic spectrum disorders reflect superficial similarities or etiological commonalities? N Am J Med Sci (Boston). 2011;4:124-133.
35. Crespi B, Badcock C. Psychosis and autism as diametrical disorders of the social brain. Behav Brain Sci. 2008;31:241-261; discussion 61-320.
36. Russell-Smith SN, Maybery MT, Bayliss DM. Are the autism and positive schizotypy spectra diametrically opposed in local versus global processing? J Autism Dev Disord. 2010;40:968-977.
37. Rees E, Kirov G, Sanders A, et al. Evidence that duplications of 22q11.2 protect against schizophrenia. Mol Psychiatr. 2014;19:37-40.
38. Sanders SJ, Ercan-Sencicek AG, Hus V, et al. Multiple recurrent de novo CNVs, including duplications of the 7q11.23 Williams syndrome region, are strongly associated with autism. Neuron. 2011;70:863-885.
39. Volavka J, Citrome L. Pathways to aggression in schizophrenia affect results of treatment. Schizophr Bull. 2011;37:921-929.
40. Motzkin JC, Newman JP, Kiehl KA, Koenigs M. Reduced prefrontal connectivity in psychopathy. J Neurosci. 2011;31:17348-17357.
41. Ly M, Motzkin JC, Philippi CL, et al. Cortical thinning in psychopathy. Am J Psychiatry. 2012;169:743-749.
42. Matheson SL, Shepherd AM, Pinchbeck RM, Laurens KR, Carr VJ. Childhood adversity in schizophrenia: a systematic meta-Analysis. Psychol Med. 2013;43:225-238.
43. Kumari V, Gudjonsson GH, Raghuvanshi S, et al. Reduced thalamic volume in men with antisocial personality disorder or schizophrenia and a history of serious violence and childhood abuse. Eur Psychiatr. 2013;28:225-234.
44. Tchanturia K, Davies H, Roberts M, et al. Poor cognitive flexibility in eating disorders: examining the evidence using the Wisconsin Card Sorting Task. PLoS One. 2012;7:e28331.
45. Tchanturia K, Davies H, Lopez C, Schmidt U, Treasure J, Wykes T. Neuropsychological task performance before and after cognitive remediation in anorexia nervosa: a pilot caseseries. Psychol Med. 2008;38:1371-1373.
46. Fonville L, Lao-Kaim NP, Giampietro V, et al. Evaluation of enhanced attention to local detail in anorexia nervosa using the embedded figures test; an FMRI study. PLoS One. 2013;8:e63964.
47. Feusner JD, Hembacher E, Moller H, Moody TD. Abnormalities of object visual processing in body dysmorphic disorder. Psychol Med. 2011;41:1-13.
48. Feusner JD, Moller H, Altstein L, et al. Inverted face processing in body dysmorphic disorder. J Psychiatr Res. 2010;44:1088-1094.
49. Feusner JD, Moody T, Hembacher E, et al. Abnormalities of visual processing and frontostriatal systems in body dysmorphic disorder. Arch Gen Psychiatr. 2010;67:197-205.
50. Silverstein SM, Keane BP. Perceptual organization impairment in schizophrenia and associated brain mechanisms: review of research from 2005 to 2010. Schizophr Bull. 2011;37:690-699.
51. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP. Medical comorbidity in schizophrenia. Schizophr Bull. 1996;22:413-430.
52. Feigenson KA, Kusnecov AW, Silverstein SM. Inflammation and the two-hit hypothesis of schizophrenia. Neurosci Biobehav Rev. 2013;38C:72-93.
53. Cuthbert BN, Insel TR. Toward new approaches to psychotic disorders: the NIMH Research Domain Criteria Project. Schizophr Bull. 2010;36:1061-1062.
54. Silverstein SM, Wang Y, Roche MW. Base rates, blindness, and schizophrenia. Front Psychol. 2013;4:157.
55. Silverstein SM, Wang Y, Keane BP. Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia. Front Psychol. 2012;3:624.
56. Mors O, Mortensen PB, Ewald H. A population-based register study of the association between schizophrenia and rheumatoid arthritis. Schizophr Res. 1999;40(1):67-74.
57. Oken RJ, Schulzer M. At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. Schizophr Bull. 1999;25:625-638.
58. Allport GW. The general and the unique in psychological science. J Pers. 1962;30:405-422.